Last checked at 20 Dec 2022 07:00
20 December 2022
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Accrol Group Holdings plc
("Accrol" or the "Company")
Director Dealing
Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Gareth Jenkins, the Chief Executive Officer, for personal reasons, has sold 1,000,000 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 28.0 pence per Ordinary share.
Following this disposal, Gareth is interested in 4,422,9291 Ordinary Shares representing 1.39% of the issued share capital of the Company.
13,741,346 of these Ordinary Shares are registered in the name of Gareth's wife Susan Jenkins.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Gareth Jenkins | ||||
2 | Reason for the notification | |||||
a) | Position/status | CEO | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Accrol Group Holdings plc | ||||
b) | LEI | 213800MC56M5G69RJ226 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 | ||||
b) | Nature of the transaction | Sale of Ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Date of the transaction | 19 December 2022 | ||||
e) | Place of the transaction | London Stock Exchange, AIM | ||||
For further information, please contact: |
|
| |
Accrol Group Holdings plc | |
Dan Wright, Executive Chairman | Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer | |
Richard Newman, Chief Financial Officer | |
| |
Zeus (Nominated Adviser & Broker) |
|
Dan Bate / Jordan Warburton | Tel: +44 (0) 161 831 1512 |
Dominic King | Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) | Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas | |
Belvedere Communications Limited | |
Cat Valentine | Tel: +44 (0) 7715 769 078 |
Keeley Clarke | Tel: +44 (0) 7967 816 525 |
accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at £2.1bn at retail sales value.
The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today.
For more information, please visit www.accrol.co.uk